What is Spherotech?
Spherotech, Inc. operates as a specialized manufacturer of high-precision polymer microparticles, including polystyrene and polymethylmethacrylate microspheres. The company serves as a foundational supplier for the scientific and research communities, providing essential components for flow cytometry, absolute cell counting, and multiplex bead assays. By offering a diverse portfolio of functionalized options and custom product development, Spherotech maintains a competitive edge in the biotechnology and diagnostic imaging markets. Their commitment to technical assistance and rigorous quality standards positions them as a key partner for laboratories and research institutions worldwide.
How much funding has Spherotech raised?
Spherotech has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Spherotech
PPP
Public-Private Partnership
What's next for Spherotech?
Following this major strategic investment, Spherotech is well-positioned to accelerate its research and development initiatives and expand its manufacturing capacity to meet the growing demand for high-fidelity diagnostic tools. The company is expected to leverage this capital to enhance its product offerings in the nanoparticle space and further penetrate the global flow cytometry market. By optimizing its supply chain and increasing its technical support infrastructure, Spherotech aims to reinforce its market leadership, ensuring that its specialized microspheres remain the industry standard for calibration and imaging applications in the evolving landscape of life sciences.
See full Spherotech company page
